Tom Emerick and Al Lewis

1 POSTS 0 COMMENTS
President of Emerick Consulting LLC, Emerick has long experience in health benefits design, global healthcare challenges, healthcare economics, evidence-based medicine, and process improvement. He spent fifteen years at Walmart, designing and managing benefits for over 1.6 million employees. In addition, he has held positions with Burger King Corporation, British Petroleum, and American Fidelity Assurance Company. Lewis, President of the Disease Management Purchasing Consortium, is also the author of Why Nobody Believes the Numbers (Wiley). He provides procurement and outcomes consulting to health plans and human resources/benefits departments, and administers the industry certification program in Critical Outcomes Report Analysis. Tom Emerick and Al Lewis are coauthors of Cracking Health Costs, published by Wiley.

Six Reasons Why Your Company’s Medical Screening Program Could Be Counterproductive

We know most CEOs are struggling with healthcare costs. A recent Bank of America survey found that most CFOs continue to list healthcare costs as their major concern. This is despite the seemingly ubiquitous wellness programs that are supposed to reduce these costs by 26%, but in reality have delivered trivial savings at best, according to the recent RAND report. There are remedies at hand.
- Advertisement -
- Advertisement -

FEATURED CONTENT

New Poll: CEOs Find Challenges In Using Customer Data To Drive Innovation

Ability to harness and sort through data for meaningful insights remains a hurdle, many say. “The key is...finding what is actually relevant.”

SUBSCRIBE TO CHIEF EXECUTIVE

Sign Up to Receive Chief Executive Magazine

Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.

CEO CONFIDENCE INDEX

CEO Confidence Continues To Slide In September As Labor, Washington And Covid Worries Grow

Chief Executive’s latest poll finds U.S. CEOs increasingly concerned that labor shortages and Biden-era policies will stall chances to rebound from the pandemic.